PIR Treatment

Well Cell’s patented approach called Physiologic Insulin Resensitization™ is directed by physicians to help patients with insulin resistance. The terms identify the PIR protocol as a resource available to physicians and their QHPs to:

• Evaluate patients diagnosed with diabetes
• Use an FDA-approved pump for precision dosing
• Benefit from Well Cell’s training and teaching services
• Contribute to peer-reviewed publications

Through the use of Physician-Directed Physiologic Insulin Resensitization (PIR), the physician can administer insulin more precisely, as a hormone rather than a drug. Using insulin in a manner that bio-mimics normal physiology, PIR is designed to help physicians to reduce their patients’ insulin resistance, which may help blood sugar more readily enter each cell and be converted into energy.